Overview

Bodewell Products for the Treatment of Atopic Dermatitis

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the safety and efficacy of topical application of the Bodewell eczema products
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
Procter and Gamble